APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nivolumab

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Nivolumab Industry Growth and Trends Forecast to 2032

23 December 202579 pages

Choose your research edition.

Industry ResearchNivolumab Industry Research Report 2026110 pages · $2,950 USDIndustry Growth & TrendsGlobal Nivolumab Industry Growth and Trends Forecast to 203279 pages · $3,450 USDMarket StructureGlobal Nivolumab Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032177 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nivolumab Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Nivolumab Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Nivolumab market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Nivolumab is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Nivolumab is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nivolumab is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Nivolumab include Ono Pharmaceutical and Bristol-Myers Squibb among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Nivolumab market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Nivolumab market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Nivolumab market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Nivolumab.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Nivolumab market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Nivolumab Market by Company

Ono Pharmaceutical

Bristol-Myers Squibb

Nivolumab Segment by Type

Injection 4mL

Injection 10mL

Nivolumab Segment by Application

Metastatic Squamous NSCLC

Metastatic Melanoma

Renal Cell Carcinoma

Classical Hodgkin Lymphoma

Unresectable Melanoma

Others

Nivolumab Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nivolumab market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nivolumab and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nivolumab.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Nivolumab manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Nivolumab in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Injection 4mL Table 2. Major Company of Injection 10mL Table 3. Global Nivolumab Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Nivolumab Sales by Type (2021-2026) & (k units) Table 5. Global Nivolumab Sales Market Share in Volume by Type (2021-2026) Table 6. Global Nivolumab Sales by Type (2021-2026) & (US$ Million) Table 7. Global Nivolumab Sales Market Share in Value by Type (2021-2026) Table 8. Global Nivolumab Price by Type (2021-2026) & (US$/unit) Table 9. Global Nivolumab Sales by Type (2027-2032) & (k units) Table 10. Global Nivolumab Sales Market Share in Volume by Type (2027-2032) Table 11. Global Nivolumab Sales by Type (2027-2032) & (US$ Million) Table 12. Global Nivolumab Sales Market Share in Value by Type (2027-2032) Table 13. Global Nivolumab Price by Type (2027-2032) & (US$/unit) Table 14. North America Nivolumab Sales by Type (2021-2026) & (k units) Table 15. North America Nivolumab Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Nivolumab Sales by Type (2021-2026) & (k units) Table 17. Europe Nivolumab Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Nivolumab Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Nivolumab Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Nivolumab Sales by Type (2021-2026) & (k units) Table 21. Latin America Nivolumab Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Nivolumab Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Nivolumab Sales by Type (2021-2026) & (US$ Million) Table 24. Nivolumab Industry Trends Table 25. Nivolumab Industry Drivers Table 26. Nivolumab Industry Opportunities and Challenges Table 27. Nivolumab Industry Restraints Table 28. Global Nivolumab Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Nivolumab Revenue Market Share by Company (2021-2026) Table 30. Global Nivolumab Sales by Company (2021-2026) & (k units) Table 31. Global Nivolumab Sales Share by Company (2021-2026) Table 32. Global Nivolumab Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Nivolumab Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Nivolumab Major Company Production Sites and Headquarters Table 35. Global Nivolumab Company, Product Type & Application Table 36. Global Nivolumab Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Nivolumab by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Nivolumab Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Nivolumab Sales by Region (2021-2026) & (k units) Table 41. Global Nivolumab Sales Market Share in Volume by Region (2021-2026) Table 42. Global Nivolumab Sales by Region (2021-2026) & (US$ Million) Table 43. Global Nivolumab Sales Market Share in Value by Region (2021-2026) Table 44. Global Nivolumab Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Nivolumab Sales by Region (2027-2032) & (k units) Table 46. Global Nivolumab Sales Market Share in Volume by Region (2027-2032) Table 47. Global Nivolumab Sales by Region (2027-2032) & (US$ Million) Table 48. Global Nivolumab Sales Market Share in Value by Region (2027-2032) Table 49. Global Nivolumab Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Nivolumab Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Nivolumab Sales by Application (2021-2026) & (k units) Table 52. Global Nivolumab Sales Market Share in Volume by Application (2021-2026) Table 53. Global Nivolumab Sales by Application (2021-2026) & (US$ Million) Table 54. Global Nivolumab Sales Market Share in Value by Application (2021-2026) Table 55. Global Nivolumab Price by Application (2021-2026) & (US$/unit) Table 56. Global Nivolumab Sales by Application (2027-2032) & (k units) Table 57. Global Nivolumab Sales Market Share in Volume by Application (2027-2032) Table 58. Global Nivolumab Sales by Application (2027-2032) & (US$ Million) Table 59. Global Nivolumab Sales Market Share in Value by Application (2027-2032) Table 60. Global Nivolumab Price by Application (2027-2032) & (US$/unit) Table 61. North America Nivolumab Sales by Application (2021-2026) & (k units) Table 62. North America Nivolumab Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Nivolumab Sales by Application (2021-2026) & (k units) Table 64. Europe Nivolumab Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Nivolumab Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Nivolumab Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Nivolumab Sales by Application (2021-2026) & (k units) Table 68. Latin America Nivolumab Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Nivolumab Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Nivolumab Sales by Application (2021-2026) & (US$ Million) Table 71. Ono Pharmaceutical Company Information Table 72. Ono Pharmaceutical Business Overview Table 73. Ono Pharmaceutical Nivolumab Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Ono Pharmaceutical Nivolumab Product Portfolio Table 75. Ono Pharmaceutical Recent Development Table 76. Bristol-Myers Squibb Company Information Table 77. Bristol-Myers Squibb Business Overview Table 78. Bristol-Myers Squibb Nivolumab Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Bristol-Myers Squibb Nivolumab Product Portfolio Table 80. Bristol-Myers Squibb Recent Development Table 81. North America Nivolumab Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 82. North America Nivolumab Sales by Country (2021-2026) & (k units) Table 83. North America Nivolumab Sales Market Share by Country (2021-2026) Table 84. North America Nivolumab Sales Forecast by Country (2027-2032) & (k units) Table 85. North America Nivolumab Sales Market Share Forecast by Country (2027-2032) Table 86. North America Nivolumab Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 87. North America Nivolumab Market Size by Country (2021-2026) & (US$ Million) Table 88. North America Nivolumab Market Share by Country (2021-2026) Table 89. North America Nivolumab Market Size Forecast by Country (2027-2032) & (US$ Million) Table 90. North America Nivolumab Market Share Forecast by Country (2027-2032) Table 91. Europe Nivolumab Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 92. Europe Nivolumab Sales by Country (2021-2026) & (k units) Table 93. Europe Nivolumab Sales Market Share by Country (2021-2026) Table 94. Europe Nivolumab Sales Forecast by Country (2027-2032) & (k units) Table 95. Europe Nivolumab Sales Market Share Forecast by Country (2027-2032) Table 96. Europe Nivolumab Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 97. Europe Nivolumab Market Size by Country (2021-2026) & (US$ Million) Table 98. Europe Nivolumab Market Share by Country (2021-2026) Table 99. Europe Nivolumab Market Size Forecast by Country (2027-2032) & (US$ Million) Table 100. Europe Nivolumab Market Share Forecast by Country (2027-2032) Table 101. Asia-Pacific Nivolumab Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 102. Asia-Pacific Nivolumab Sales by Country (2021-2026) & (k units) Table 103. Asia-Pacific Nivolumab Sales Market Share by Country (2021-2026) Table 104. Asia-Pacific Nivolumab Sales Forecast by Country (2027-2032) & (k units) Table 105. Asia-Pacific Nivolumab Sales Market Share Forecast by Country (2027-2032) Table 106. Asia-Pacific Nivolumab Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. Asia-Pacific Nivolumab Market Size by Country (2021-2026) & (US$ Million) Table 108. Asia-Pacific Nivolumab Market Share by Country (2021-2026) Table 109. Asia-Pacific Nivolumab Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. Asia-Pacific Nivolumab Market Share Forecast by Country (2027-2032) Table 111. Latin America Nivolumab Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 112. Latin America Nivolumab Sales by Country (2021-2026) & (k units) Table 113. Latin America Nivolumab Sales Market Share by Country (2021-2026) Table 114. Latin America Nivolumab Sales Forecast by Country (2027-2032) & (k units) Table 115. Latin America Nivolumab Sales Market Share Forecast by Country (2027-2032) Table 116. Latin America Nivolumab Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Latin America Nivolumab Market Size by Country (2021-2026) & (US$ Million) Table 118. Latin America Nivolumab Market Share by Country (2021-2026) Table 119. Latin America Nivolumab Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Latin America Nivolumab Market Share Forecast by Country (2027-2032) Table 121. Middle East and Africa Nivolumab Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 122. Middle East and Africa Nivolumab Sales by Country (2021-2026) & (k units) Table 123. Middle East and Africa Nivolumab Sales Market Share by Country (2021-2026) Table 124. Middle East and Africa Nivolumab Sales Forecast by Country (2027-2032) & (k units) Table 125. Middle East and Africa Nivolumab Sales Market Share Forecast by Country (2027-2032) Table 126. Middle East and Africa Nivolumab Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Middle East and Africa Nivolumab Market Size by Country (2021-2026) & (US$ Million) Table 128. Middle East and Africa Nivolumab Market Share by Country (2021-2026) Table 129. Middle East and Africa Nivolumab Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Middle East and Africa Nivolumab Market Share Forecast by Country (2027-2032) Table 131. Key Raw Materials Table 132. Raw Materials Key Suppliers Table 133. Nivolumab Distributors List Table 134. Nivolumab Customers List Table 135. Research Programs/Design for This Report Table 136. Authors List of This Report Table 137. Secondary Sources Table 138. Primary Sources List of Figures Figure 1. Nivolumab Image Figure 2. Global Nivolumab Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nivolumab Market Size (2021-2032) & (US$ Million) Figure 4. Global Nivolumab Sales (2021-2032) & (k units) Figure 5. Injection 4mL Image Figure 6. Global Injection 4mL Sales YoY Growth (2021-2032) & (k units) Figure 7. Injection 10mL Image Figure 8. Global Injection 10mL Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Nivolumab Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Nivolumab Market Share by Type 2025 VS 2032 Figure 11. North America Nivolumab Sales Market Share in Volume by Type in 2025 Figure 12. North America Nivolumab Sales Market Share in Value by Type in 2025 Figure 13. Europe Nivolumab Sales Market Share in Volume by Type in 2025 Figure 14. Europe Nivolumab Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Nivolumab Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Nivolumab Sales Market Share in Value by Type in 2025 Figure 17. Latin America Nivolumab Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Nivolumab Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Nivolumab Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Nivolumab Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Nivolumab Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Metastatic Squamous NSCLC Image Figure 24. Global Metastatic Squamous NSCLC Sales YoY Growth (2021-2032) & (k units) Figure 25. Metastatic Melanoma Image Figure 26. Global Metastatic Melanoma Sales YoY Growth (2021-2032) & (k units) Figure 27. Renal Cell Carcinoma Image Figure 28. Global Renal Cell Carcinoma Sales YoY Growth (2021-2032) & (k units) Figure 29. Classical Hodgkin Lymphoma Image Figure 30. Global Classical Hodgkin Lymphoma Sales YoY Growth (2021-2032) & (k units) Figure 31. Unresectable Melanoma Image Figure 32. Global Unresectable Melanoma Sales YoY Growth (2021-2032) & (k units) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 35. Global Nivolumab Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Nivolumab Market Share by Application 2025 VS 2032 Figure 37. North America Nivolumab Sales Market Share in Volume by Application in 2025 Figure 38. North America Nivolumab Sales Market Share in Value by Application in 2025 Figure 39. Europe Nivolumab Sales Market Share in Volume by Application in 2025 Figure 40. Europe Nivolumab Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Nivolumab Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Nivolumab Sales Market Share in Value by Application in 2025 Figure 43. Latin America Nivolumab Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Nivolumab Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Nivolumab Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Nivolumab Sales Market Share in Value by Application in 2025 Figure 47. North America Nivolumab Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. North America Nivolumab Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Nivolumab Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Nivolumab Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Nivolumab Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Europe Nivolumab Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Nivolumab Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Nivolumab Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Nivolumab Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Asia-Pacific Nivolumab Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Nivolumab Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Nivolumab Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Nivolumab Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Latin America Nivolumab Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Nivolumab Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Nivolumab Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Nivolumab Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 64. Middle East and Africa Nivolumab Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Nivolumab Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Nivolumab Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Nivolumab Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Nivolumab Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Injection 4mL
  • Injection 10mL
Applications
  • Metastatic Squamous NSCLC
  • Metastatic Melanoma
  • Renal Cell Carcinoma
  • Classical Hodgkin Lymphoma
  • Unresectable Melanoma
  • Others
Companies covered
  • Ono Pharmaceutical
  • Bristol-Myers Squibb

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Nivolumab Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Nivolumab Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Nivolumab Market by Type
  6. 1.3.1 Injection 4mL
  7. 1.3.2 Injection 10mL
  8. 1.4 Global Nivolumab Market Size by Type
  9. 1.4.1 Global Nivolumab Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Nivolumab Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Nivolumab Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Nivolumab Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Nivolumab Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Nivolumab Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Nivolumab Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Nivolumab Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Nivolumab Industry Trends
  2. 2.2 Nivolumab Industry Drivers
  3. 2.3 Nivolumab Industry Opportunities and Challenges
  4. 2.4 Nivolumab Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Nivolumab Revenue (2021-2026)
  2. 3.2 Global Top Players by Nivolumab Sales (2021-2026)
  3. 3.3 Global Top Players by Nivolumab Price (2021-2026)
  4. 3.4 Global Nivolumab Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Nivolumab Major Company Production Sites & Headquarters
  6. 3.6 Global Nivolumab Company, Product Type & Application
  7. 3.7 Global Nivolumab Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Nivolumab Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Nivolumab Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Nivolumab Tier 1, Tier 2, and Tier 3
4 Nivolumab Regional Status and Outlook
  1. 4.1 Global Nivolumab Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Nivolumab Historic Market Size by Region
  3. 4.2.1 Global Nivolumab Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Nivolumab Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Nivolumab Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Nivolumab Forecasted Market Size by Region
  7. 4.3.1 Global Nivolumab Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Nivolumab Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Nivolumab Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Nivolumab by Application
  1. 5.1 Nivolumab Market by Application
  2. 5.1.1 Metastatic Squamous NSCLC
  3. 5.1.2 Metastatic Melanoma
  4. 5.1.3 Renal Cell Carcinoma
  5. 5.1.4 Classical Hodgkin Lymphoma
  6. 5.1.5 Unresectable Melanoma
  7. 5.1.6 Others
  8. 5.2 Global Nivolumab Market Size by Application
  9. 5.2.1 Global Nivolumab Market Size Overview by Application (2021-2032)
  10. 5.2.2 Global Nivolumab Historic Market Size Review by Application (2021-2026)
  11. 5.2.3 Global Nivolumab Forecasted Market Size by Application (2027-2032)
  12. 5.3 Key Regions Market Size by Application
  13. 5.3.1 North America Nivolumab Sales Breakdown by Application (2021-2026)
  14. 5.3.2 Europe Nivolumab Sales Breakdown by Application (2021-2026)
  15. 5.3.3 Asia-Pacific Nivolumab Sales Breakdown by Application (2021-2026)
  16. 5.3.4 South America Nivolumab Sales Breakdown by Application (2021-2026)
  17. 5.3.5 Middle East and Africa Nivolumab Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Ono Pharmaceutical
  2. 6.1.1 Ono Pharmaceutical Company Information
  3. 6.1.2 Ono Pharmaceutical Business Overview
  4. 6.1.3 Ono Pharmaceutical Nivolumab Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Ono Pharmaceutical Nivolumab Product Portfolio
  6. 6.1.5 Ono Pharmaceutical Recent Developments
  7. 6.2 Bristol-Myers Squibb
  8. 6.2.1 Bristol-Myers Squibb Company Information
  9. 6.2.2 Bristol-Myers Squibb Business Overview
  10. 6.2.3 Bristol-Myers Squibb Nivolumab Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Bristol-Myers Squibb Nivolumab Product Portfolio
  12. 6.2.5 Bristol-Myers Squibb Recent Developments
7 North America by Country
  1. 7.1 North America Nivolumab Sales by Country
  2. 7.1.1 North America Nivolumab Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Nivolumab Sales by Country (2021-2026)
  4. 7.1.3 North America Nivolumab Sales Forecast by Country (2027-2032)
  5. 7.2 North America Nivolumab Market Size by Country
  6. 7.2.1 North America Nivolumab Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Nivolumab Market Size by Country (2021-2026)
  8. 7.2.3 North America Nivolumab Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Nivolumab Sales by Country
  2. 8.1.1 Europe Nivolumab Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Nivolumab Sales by Country (2021-2026)
  4. 8.1.3 Europe Nivolumab Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Nivolumab Market Size by Country
  6. 8.2.1 Europe Nivolumab Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Nivolumab Market Size by Country (2021-2026)
  8. 8.2.3 Europe Nivolumab Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Nivolumab Sales by Country
  2. 9.1.1 Asia-Pacific Nivolumab Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Nivolumab Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Nivolumab Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Nivolumab Market Size by Country
  6. 9.2.1 Asia-Pacific Nivolumab Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Nivolumab Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Nivolumab Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Nivolumab Sales by Country
  2. 10.1.1 South America Nivolumab Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Nivolumab Sales by Country (2021-2026)
  4. 10.1.3 South America Nivolumab Sales Forecast by Country (2027-2032)
  5. 10.2 South America Nivolumab Market Size by Country
  6. 10.2.1 South America Nivolumab Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Nivolumab Market Size by Country (2021-2026)
  8. 10.2.3 South America Nivolumab Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Nivolumab Sales by Country
  2. 11.1.1 Middle East and Africa Nivolumab Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Nivolumab Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Nivolumab Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Nivolumab Market Size by Country
  6. 11.2.1 Middle East and Africa Nivolumab Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Nivolumab Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Nivolumab Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Nivolumab Value Chain Analysis
  2. 12.1.1 Nivolumab Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Nivolumab Production Mode & Process
  7. 12.2 Nivolumab Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Nivolumab Distributors
  10. 12.2.3 Nivolumab Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst